About PharmaCyte Biotech
PharmaCyte Biotech is a company based in Silver Spring (United States) founded in 1996.. The company has 2 employees as of April 30, 2024. PharmaCyte Biotech offers products and services including Biotech Solutions. PharmaCyte Biotech operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Silver Spring, United States
- Employees 2 as on 30 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pharmacyte Biotech, Inc.
-
Annual Revenue
$00as on Apr 30, 2024
-
Net Profit
$30.66 M9084.98as on Apr 30, 2025
-
EBITDA
$-4.38 M32.86as on Apr 30, 2025
-
Latest Funding Round
$7 M (USD), Post-IPO
Aug 17, 2025
-
Investors
-
Employee Count
2
as on Apr 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PharmaCyte Biotech
PharmaCyte Biotech is a publicly listed company on the NASDAQ with ticker symbol PMCB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PharmaCyte Biotech
PharmaCyte Biotech offers a comprehensive portfolio of products and services, including Biotech Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Clinical stage biotechnology services for innovation and governance
Unlock access to complete
Unlock access to complete
Funding Insights of PharmaCyte Biotech
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $7.0M
-
First Round
First Round
(27 Dec 2013)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Post-IPO - PharmaCyte Biotech | Valuation |
investors |
|
| Jan, 2016 | Amount | Post-IPO - PharmaCyte Biotech | Valuation |
investors |
|
| Jan, 2016 | Amount | Post-IPO - PharmaCyte Biotech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by PharmaCyte Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PharmaCyte Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pharmacyte Biotech Comparisons
Competitors of PharmaCyte Biotech
PharmaCyte Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pharmacyte Biotech
Frequently Asked Questions about PharmaCyte Biotech
When was PharmaCyte Biotech founded?
PharmaCyte Biotech was founded in 1996 and raised its 1st funding round 17 years after it was founded.
Where is PharmaCyte Biotech located?
PharmaCyte Biotech is headquartered in Silver Spring, United States. It is registered at Silver Spring, Maryland, United States.
How many employees does PharmaCyte Biotech have?
As of Apr 30, 2024, the latest employee count at PharmaCyte Biotech is 2.
What does PharmaCyte Biotech do?
Founded in 1996 and based in Silver Spring, United States, PharmaCyte Biotech operates in the biotechnology sector. Targeted therapeutics are developed for cancer and diabetes through proprietary Cell-in-a-box technology, by which drugs are encapsulated to enhance pharmacokinetic performance and extend half-life. Candidates are applied to pancreatic cancer, brain cancer, abdominal cancer, diabetes, and related conditions.
Who are the top competitors of PharmaCyte Biotech?
PharmaCyte Biotech's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does PharmaCyte Biotech offer?
PharmaCyte Biotech offers Biotech Solutions.
Is PharmaCyte Biotech publicly traded?
Yes, PharmaCyte Biotech is publicly traded on NASDAQ under the ticker symbol PMCB.
What is PharmaCyte Biotech's ticker symbol?
The ticker symbol of PharmaCyte Biotech is PMCB on NASDAQ.